首页> 外国专利> A pharmaceutical composition for preventing or treating a human cytomegalovirus disease comprising a gamma secretase inhibitor and a method for screening a therapeutic agent for a human cytomegalovirus disease using gamma secretase

A pharmaceutical composition for preventing or treating a human cytomegalovirus disease comprising a gamma secretase inhibitor and a method for screening a therapeutic agent for a human cytomegalovirus disease using gamma secretase

机译:包含γ分泌酶抑制剂的用于预防或治疗人巨细胞病毒疾病的药物组合物以及使用γ分泌酶筛选用于人巨细胞病毒疾病的治疗剂的方法

摘要

The present invention relates to a pharmaceutical composition for the prevention or treatment of a human cytomegalovirus infection disease comprising a gamma secretase inhibitor, and a screening method of a therapeutic agent for the treatment of a human cytomegalovirus infection disease using gamma secretase, a therapeutic agent for Alzheimer's or anticancer agent By confirming that inhibitors for various gamma secretase enzymes developed for the purpose of inhibiting the proliferation of human cytomegalovirus, suggests the possibility of development as a new therapeutic agent for human cytomegalovirus infection, brain development disorder, various types It is expected to be used as an antiviral drug against human cytomegalovirus, which causes cancer and even death of people with weakened immunity.
机译:预防和治疗人巨细胞病毒感染疾病的药物组合物本发明涉及一种包含γ分泌酶抑制剂的预防或治疗人巨细胞病毒感染疾病的药物组合物,以及使用γ分泌酶的人巨细胞病毒感染疾病的治疗剂的筛选方法。阿尔茨海默氏症或抗癌药通过确认开发出多种抑制人巨细胞病毒增殖的γ分泌酶抑制剂,表明有可能发展为新型治疗人巨细胞病毒感染,脑发育障碍,各种类型的药物。用作抗人类巨细胞病毒的抗病毒药,可导致癌症,甚至导致免疫力低下的人死亡。

著录项

  • 公开/公告号KR102130281B1

    专利类型

  • 公开/公告日2020-07-08

    原文格式PDF

  • 申请/专利权人 성균관대학교산학협력단;

    申请/专利号KR20200074832

  • 发明设计人 윤기정;한다솔;

    申请日2020-06-19

  • 分类号A61K31/16;A61K31/165;A61K31/5513;A61P31/12;A61P35;G01N33/573;

  • 国家 KR

  • 入库时间 2022-08-21 11:04:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号